Navigation Links
Lung airway cells activate vitamin D and increase immune response
Date:11/3/2008

the airway cells helps convert the storage form of vitamin D into its active form.

"When we put the storage form of vitamin D on the lung airway cells, we saw them convert it to the active form," Hansdottir said. "The next step was to investigate whether this active form could affect the expression of genes."

The team then showed that vitamin D activated by airway cells affects two genes involved in immune defense. One gene expresses a protein called cathelicidin that can kill bacteria. The second gene, called CD14, produces a protein that helps cells recognize different kinds of pathogens that could be a threat.

"Vitamin D converted by the kidneys circulates in the bloodstream, but vitamin D converted by other organs appears to stay within those organs and protect them from infection," Hansdottir said. "We were able to see this happen in cells lining the trachea and main bronchi."

The team also found that when lung airway cells are infected by a virus, they express more of the enzyme that activates vitamin D. Hansdottir said the team is very interested in pursuing studies on the role of viral infections in vitamin D production and subsequent effects on lung infections.

"Vitamin D not only increases proteins involved in bacterial killing but also can dampen inflammation," Hansdottir said. "Controlling inflammation through vitamin D is good because too much inflammation can cause problems such as sepsis and seems to contribute to autoimmune disease."

Hansdottir noted that vitamin D insufficiencies and deficiencies (which are more severe) are fairly common, particularly for people living in northern latitudes. While vitamin D can be generated through sun exposure, such exposure is generally not recommended as a remedy because of skin cancer risks. Instead, supplements can be used.

The American Academy of Pediatrics recently recommended that the vitamin D dosage for children be increased to 400 IU (inte
'/>"/>

Contact: Becky Soglin
becky-soglin@uiowa.edu
319-335-6660
University of Iowa
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Franklin Square to study airway bypass procedure for severe emphysema
2. Researchers at Sarasota Memorial Health Care System to study airway bypass treatment for emphysema
3. Positive results for airway bypass
4. New method provides panoramic view of protein-RNA interactions in living cells
5. Simple chemical procedure augments therapeutic potential of stem cells
6. Researchers at UH explore use of fat cells as heart attack therapy
7. Mediator in communication between neurons and muscle cells found
8. JDRF to provide $1M in funding to SmartCells, Inc.
9. Seemingly suicidal stunt is normal rite of passage for immune cells
10. Swamping bad cells with good in ALS animal models helps sustain breathing
11. Forsyth scientists trigger cancer-like response from embryonic stem cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)... Cells constantly compete with one another for spa...cells win this competition is well known to be the...ut for space and survival is not as clear. A study...f Science by Johns Hopkins researchers describes...ing around. , "Our work exemplifies how one sign...
(Date:12/4/2009)...a Texas AgriLife Research plant physiologist at th...Uvalde, has been investigating ways to help vegeta...he greenhouse to the field. , "This research can...n the further profitability of some vegetable crop...that will establish well," Leskovar said. "It coul...
(Date:12/4/2009)... an analysis of statewide data taken from 1998-200...ar were more than three times likely to report the...ecause of their insurance status during pregnancy ...ance-based discrimination was also three times mor... four times more likely among women who did not ha...
Breaking Biology News(10 mins):Stem cells battle for space 2Texas AgriLife researchers helping 2Texas AgriLife researchers helping 3Texas AgriLife researchers helping 4Lower income women report more insurance-based discrimination during pregnancy, delivery 2BIO Ventures for Global Health Announces Management Changes 12785 1BIO Ventures for Global Health Announces Management Changes 12785 2Hospice of Michigan President and CEO Available for Comment on New England Journal of Medicine Article on Profits in Hospice Industry and Proposed Cha 50037 1Hospice of Michigan President and CEO Available for Comment on New England Journal of Medicine Article on Profits in Hospice Industry and Proposed Cha 50037 2Hospice of Michigan President and CEO Available for Comment on New England Journal of Medicine Article on Profits in Hospice Industry and Proposed Cha 50037 3Connectyx Technologies Holdings Group Inc to Host Nationwide Teleconference on July 9 2009 50033 1Connectyx Technologies Holdings Group Inc to Host Nationwide Teleconference on July 9 2009 50033 2
...ng cancer should be an occasion for rejoicing, man...ose chemotherapy to defeat the disease unfortunate... as "chemobrain." This cognitively dysfunctional s...ous learning impairment due to possible brain dama...T YOUR MIND (Prometheus Books, $18.98), a clear, ...
... Genomic Regulation (CRG) in Barcelona, Spain purc...unced today by Genomatix Software GmbH. , GGA comp...terabytes of proprietary databases and software pr...xt Generation Sequencing (NGS) data after mapping ...ve it! And I have advertised it to many colleagues...
... As researchers continue to examine the role of s... understand the differences among various ingredie...Corn Refiners Association (CRA). Interchanging two...ructose and high fructose corn syrup, creates fact...s. , Recent studies using pure fructose that pur...
Other Biology News:ChemoBrain: How cancer therapies can affect your mind 2CRG buys Genomatix' Next Generation Sequencing analysis solution 2Pure fructose frequently confused with high fructose corn syrup 2
(Date:12/3/2009)..., , DALLAS, Dec. 3 /PRNewswire-FirstCa...letin Board: ACCP), today provided an update on it...roved treatment for oral mucositis, a debilitating...py. MuGard is commercially launched by Access, par...ng the UK, Germany, Italy, Norway, Greece and Swed...
(Date:12/3/2009)..., , PHILADELPHIA, Dec. 3 /PRNewswire-FirstC... global specialty biopharmaceutical company, today...untary market withdrawal of one lot of the Attenti...trana ® . Shire is taking this action because...e may not meet their release liner removal specifi...
(Date:12/3/2009)..., , WALTHAM, Mass., Dec. 3 /PRNewswire-Firs...E: IMA ), a global leader in enabling individual...he merger of rapid diagnostics and health manageme...its Series B Convertible Perpetual Preferred Stock... Series B stock in an amount per share equal to th...
(Date:12/3/2009)..., , NEW DELHI, India, Dec. 3 /PR...ief Science Officer at Shenzhen Beike Biotechnolog... at a conference on High-Risk Diabetic,Foot Care i...ina,s leading,stem cell research and regenerative ...ized by the Indian Podiatry Association (IPA), aim...
Breaking Biology Technology:Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 2Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 3Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 4Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 2Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 3Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 4Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 5Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 2Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 3
...lth,Inc. (Nasdaq: GHDX ) today announced that Kim...erations Officer, will present at the BIO CEO &,In... at 10:15 a.m. Eastern,Time., To access the live ...ion, visit the Investor Relations section of Genom...lth.com . Please connect to the website,at least 1...
...,(Nasdaq: ITMN ) today announced results from ope...mber 31, 2007. The company also provided 2008,fina...ent programs., Results for the Fourth Quarter 200...uarter of 2007 of $25.8,million, or $0.66 per shar...0.64 per share, in the fourth quarter of 2006., I...
... Guide New Service Offering, PHILADELPHIA, Feb. 7...h of a new Alzheimer,s risk assessment service,wit...a service agreement,with one of the leading labora...n at Smart Genetics is to provide people with accu...em understand and interpret,their risk and assist ...
Other Biology Technology:InterMune Announces Fourth Quarter and Full Year 2007 Financial Results and Provides 2008 Guidance 2InterMune Announces Fourth Quarter and Full Year 2007 Financial Results and Provides 2008 Guidance 3InterMune Announces Fourth Quarter and Full Year 2007 Financial Results and Provides 2008 Guidance 4InterMune Announces Fourth Quarter and Full Year 2007 Financial Results and Provides 2008 Guidance 5InterMune Announces Fourth Quarter and Full Year 2007 Financial Results and Provides 2008 Guidance 6InterMune Announces Fourth Quarter and Full Year 2007 Financial Results and Provides 2008 Guidance 7InterMune Announces Fourth Quarter and Full Year 2007 Financial Results and Provides 2008 Guidance 8InterMune Announces Fourth Quarter and Full Year 2007 Financial Results and Provides 2008 Guidance 9InterMune Announces Fourth Quarter and Full Year 2007 Financial Results and Provides 2008 Guidance 10InterMune Announces Fourth Quarter and Full Year 2007 Financial Results and Provides 2008 Guidance 11Smart Genetics Announces Plans to Launch a New Alzheimer's Risk Assessment Service 2Smart Genetics Announces Plans to Launch a New Alzheimer's Risk Assessment Service 3
Mouse Anti-Human AGTRAP Polyclonal Antibody, Unconjugated from Abnova Corporation
Mouse Anti-Human NCLN Polyclonal Antibody, Unconjugated from Abnova Corporation
5' RACE Anchor Primer from Invitrogen
Mouse Anti-Human UGT2B10 Monoclonal Antibody, Unconjugated, Clone 2D9 from Novus Biologicals
Biology Products: